Hypomagnesemia in patients with type 2 diabetes.
Hypomagnesemia has been reported to occur at an increased frequency among patients with type 2 diabetes compared with their counterparts without diabetes. Despite numerous reports linking hypomagnesemia to chronic diabetic complications, attention to this issue is poor among clinicians. This article reviews the literature on the metabolism of magnesium, incidence of hypomagnesemia in patients with type 2 diabetes, implicated contributing factors, and associated complications. Hypomagnesemia occurs at an incidence of 13.5 to 47.7% among patients with type 2 diabetes. Poor dietary intake, autonomic dysfunction, altered insulin metabolism, glomerular hyperfiltration, osmotic diuresis, recurrent metabolic acidosis, hypophosphatemia, and hypokalemia may be contributory. Hypomagnesemia has been linked to poor glycemic control, coronary artery diseases, hypertension, diabetic retinopathy, nephropathy, neuropathy, and foot ulcerations. The increased incidence of hypomagnesemia among patients with type 2 diabetes presumably is multifactorial. Because current data suggest adverse outcomes in association with hypomagnesemia, it is prudent to monitor magnesium routinely in this patient population and treat the condition whenever possible.
Pham
Phuong-Chi T
PC
Olive View-UCLA Medical Center, 14445 Olive View Drive, Department of Medicine, 2B-182, Nephrology Division, Sylmar, CA 91342, USA. pctp@ucla.edu
Pham
Phuong-Mai T
PM
Pham
Son V
SV
Miller
Jeffrey M
JM
Pham
Phuong-Thu T
PT
D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000378:metabolism; D006801:Humans; D008274:Magnesium / Q000097:blood* / Q000378:metabolism; D008659:Metabolic Diseases / Q000209:etiology* / Q000628:therapy
D008274:Magnesium